Evidence map›Paper›PMID 32010135›Full record

ArticleFrontiers in immunology2019

Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection.

Amudhan Murugesan, Chris Ibegbu, Tiffany M Styles, Andrew T Jones, Uma Shanmugasundaram, Pradeep B J Reddy, Sadia J Rahman, Piu Saha, Matam Vijay-Kumar, Esaki Muthu Shankar and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Frontiers in immunology · 2022
    Article
  12. Article
  13. Review
  14. Mouse models illuminate MAIT cell biology.Molecular immunology · 2021
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Amudhan MurugesanEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Chris IbegbuEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Tiffany M StylesEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Andrew T JonesEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Uma ShanmugasundaramEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Pradeep B J ReddyEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Sadia J RahmanEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Piu SahaDepartment of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Matam Vijay-KumarDepartment of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Esaki Muthu ShankarDepartment of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India.
Rama Rao AmaraEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Vijayakumar VeluEmory Vaccine Center, Emory University, Atlanta, GA, United States.
Emory University · USUniversity of Toledo · USCentral University of Tamil Nadu · IN

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 1985 to 2011
$114.0M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Preclinical Studies and T cell ResponsesU19AI109633 · NIAID · EMORY UNIVERSITY · PI VELU, VIJAYAKUMAR · 2014 to 2018
$10.2M
Immunologic changes associated with three progestin-based contraceptives: characterizing immune profiles over one year and identifying factors that may alter HIV riskR01HD095741 · NICHD · EMORY UNIVERSITY · PI HADDAD, LISA BLAKE, SMITH, ALICIA K · 2018 to 2022
$3.8M
NCRR NIH HHS P51 RR000165NIAID NIH HHS P30 AI050409NIAID NIH HHS U19 AI109633NICHD NIH HHS R01 HD095741NIH HHS P51 OD011132
6 · The paper itself

Abstract

Mucosa-associated invariant T (MAIT) cells are recently characterized as a novel subset of innate-like T cells that recognize microbial metabolites as presented by the MHC-1b-related protein MR1. The significance of MAIT cells in anti-bacterial defense is well-understood but not clear in viral infections such as SIV/HIV infection. Here we studied the phenotype, distribution, and function of MAIT cells and their association with plasma viral levels during chronic SHIV infection in rhesus macaques (RM). Two groups of healthy and chronic SHIV-infected macaques were characterized for MAIT cells in blood and mucosal tissues. Similar to human, we found a significant fraction of macaque T cells co-expressing MAIT cell markers CD161 and TCRVα-7.2 that correlated directly with macaque MR1 tetramer. These cells displayed memory phenotype and expressed high levels of IL-18R, CCR6, CD28, and CD95. During chronic infection, the frequency of MAIT cells are enriched in the blood but unaltered in the rectum; both blood and rectal MAIT cells displayed higher proliferative and cytotoxic phenotype post-SHIV infection. The frequency of MAIT cells in blood and rectum correlated inversely with plasma viral RNA levels and correlated directly with total CD4 T cells. MAIT cells respond to microbial products during chronic SHIV infection and correlated positively with serum immunoreactivity to flagellin levels. Tissue distribution analysis of MAIT cells during chronic infection showed significant enrichment in the non-lymphoid tissues (lung, rectum, and liver) compared to lymphoid tissues (spleen and LN), with higher levels of tissue-resident markers CD69 and CD103. Exogenous

Indexed as

Disease SusceptibilityAnimalsBiomarkersCD8-Positive T-LymphocytesHIVHIV InfectionsHost-Pathogen InteractionsHumansLymphocyte CountMacaca mulattaMucosal-Associated Invariant T CellsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocyte SubsetsBiomarkersCD8 T cellscytokine treatmentsHIV/SIV infectioninnate like T cellsMAIT cellsmicrobial metabolitesMR-1 tetramerrhesus macaques

Identifiers

PMID32010135
PMCPMC6978843
OpenAlexW3000500894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.